Olaptesed pegol
Based on 1 publication(s) in Google Scholar
Olaptesed pegol (NOX-A12) is a L-oligoribonucleotide aptamer targeting CXCL12 based on a pegylated structure. Olaptesed pegol neutralizes CXCL12, and CXCL12 inhibition mobilizes chronic lymphocytic leukemia cells into the circulation and prevents their homing into the protective microenvironment. Olaptesed pegol can enhances the infiltration of human primary T cells and NK cells and inhibit tumor growth companied with anti-PD-1 antibody. Olaptesed pegol can be used for researches of colon cancer and lymphocytic leukemia.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 95.94%
- CAS. Nr.: 1390628-22-4
- Molecular Weight:54656 (Approximately)
-
Speicherung:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications Citing Use of MedChemExpress (MCE) Olaptesed pegol
More
Biologische Aktivität
CXCL12[1]
Olaptesed pegol (10-100 nM, overnight incubation) dose-dependently enhances the infiltration of human primary T cells (CD8+, CD4+) and NK cells in heterotypic tumor-stroma spheroids (PSN-1/MS-5, HT-29/MS-5, H1299/MS-5, U251MG/MS-5) containing CXCL12, slightly promotes B cell infiltration, has no effect on monocyte infiltration, and results in low levels of Treg cell infiltration[2].
Olaptesed pegol (10 nM, combined with anti-PD-1 antibody, overnight incubation) synergizes with anti-PD-1 antibody to enhance the activation of Jurkat PD-1/luc T cells in the MS-5/CHO-PD-L1 spheroid model[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c mice bearing CT-26 colorectal cancer syngeneic tumors[2]
-
Dosage:20 mg/kg
-
Administration:Subcutaneously injection, every other day, initiated on day 5
-
Result:Inhibited tumor growth with 5 out of 8 mice responding.
Olaptesed pegol alone had no significant inhibitory effect on tumor growth.
Chemical Information
-
CAS. Nr. 1390628-22-4
-
Appearance Solid
-
Molecular Weight 54656 (Approximately)
-
Color White to off-white
-
SMILES
[Olaptesed pegol]
-
Synonyms
NOX-A12
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (1)
-
Journal Impact Factor
-
Most Recent
Reinheit & Dokumentation
-
Data Sheet (270 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2242 KB)
Verweise
[1]. Steurer M, et al. Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia. Haematologica. 2019 Oct;104(10):2053-2060. [Content Brief]
[2]. Zboralski D, et al. Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade. Cancer Immunol Res. 2017 Nov;5(11):950-956. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)